Diabetes Medicine

Product Details:

Semaglutide 0.5 mg injection is a once-weekly injectable medication used to help manage blood sugar levels in adults with type 2 diabetes. It may also aid in weight loss and is part of a broader treatment plan including diet and exercise. This GLP-1 receptor agonist mimics the action of a natural hormone to enhance insulin release, reduce glucagon secretion, and slow gastric emptying.

How It Works:
Semaglutide helps:

• Lower blood sugar levels

• Promote satiety (feeling of fullness)

• Assist in weight reduction in some patients

Administration:

• Injected subcutaneously (under the skin) once a week

• Can be self-administered in the thigh, abdomen, or upper arm

• Always use as prescribed by your healthcare provider

Who It’s For:

• Adults with type 2 diabetes not controlled by diet and exercise alone

• Individuals seeking a medically supervised weight loss plan (off-label use in some cases, consult your doctor)

Benefits:

• Improved blood glucose control

• Support for weight management

• May reduce risk of cardiovascular events in certain individuals with heart disease

Note: Not for use in type 1 diabetes or as a first-line treatment without trying other therapies.

Semaglutide 0.5 mg is primarily used to manage type 2 diabetes and improve blood sugar control. It is also increasingly used off-label to support weight loss under medical supervision.

It is injected once a week, on the same day each week, at any time of the day, with or without meals.

Yes, under the guidance of a healthcare provider. While this dosage is approved for diabetes, some patients are prescribed Semaglutide for weight loss based on clinical evaluation.

Common side effects include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Decreased appetite

Serious but rare side effects include pancreatitis, kidney issues, and thyroid tumors.

It is injected subcutaneously into the upper arm, thigh, or abdomen using a pre-filled pen. Detailed instructions are provided with each prescription.

Yes. Store unused pens in the refrigerator. Once in use, they can be kept at room temperature (up to 86°F or 30°C) for up to 56 days.

In many cases, yes. However, combinations should be discussed with your healthcare provider to avoid low blood sugar or adverse effects.

Take the missed dose as soon as possible within 5 days of the missed dose. If more than 5 days have passed, skip the dose and continue with your regular schedule.

No. Semaglutide is not insulin. It works differently by stimulating your own body’s insulin production in response to meals.

Coverage varies depending on your provider and plan. Many insurance plans, including Medicare, may cover it with prior authorization.

Product Details:

Semaglutide 1.7 mg is a once-weekly injectable medication used as part of a weight management treatment plan. It belongs to the GLP-1 receptor agonist class and is the second-to-last step in the dose escalation schedule for patients using Semaglutide for obesity or overweight with weight-related health conditions (e.g., high blood pressure, type 2 diabetes, or high cholesterol).

This dose is commonly associated with Wegovy (a brand of Semaglutide approved for chronic weight management) and is prescribed after patients tolerate lower doses like 0.25 mg, 0.5 mg, and 1.0 mg.

How It Works:
Semaglutide mimics the GLP-1 hormone to:

• Reduce appetite and cravings

• Slow digestion and promote early satiety

• Regulate blood sugar and insulin levels

• Support consistent, sustainable weight loss

Administration:

• Subcutaneous injection once per week

• Can be injected into the abdomen, thigh, or upper arm

• Provided in a prefilled pen, easy to use at home

Who It’s For:

• Adults with a BMI ≥30 (obese), or ≥27 (overweight) with a weight-related medical condition

• Patients who have successfully completed the dose escalation process

• Individuals under the care of a licensed healthcare provider for long-term weight management

Key Benefits:

• Significant weight loss support when paired with diet and physical activity

• Helps control appetite and reduce caloric intake

• May improve metabolic health markers (blood sugar, cholesterol, blood pressure)

Semaglutide 1.7 mg is primarily used as part of a medical weight loss plan. It’s one of the final dose steps before reaching the full 2.4 mg maintenance dose used in Wegovy.

Yes, Semaglutide is FDA-approved for chronic weight management under the Wegovy brand. The 1.7 mg dose is part of the stepwise titration required to safely reach the full 2.4 mg dose.

Gradual dose escalation (starting at 0.25 mg) helps your body adjust and minimizes side effects like nausea or stomach discomfort.

Once per week, on the same day each week, with or without food.

It is typically a step toward the full 2.4 mg maintenance dose, but some patients may remain on 1.7 mg if they experience good results or cannot tolerate higher doses. Your doctor will advise what’s best for you.

Common side effects include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Headache

• Decreased appetite

• Fatigue

These often lessen over time or with dose adjustments.

It is injected under the skin using a prefilled pen. The injection is quick and can be done at home after proper training.

• Unused pens: Refrigerate at 36°F to 46°F (2°C to 8°C)

• In-use pens: May be kept at room temperature (below 86°F or 30°C) for up to 56 days

A balanced, reduced-calorie diet and increased physical activity are recommended for best results. Your provider or a nutritionist may give you personalized guidance.

Product Details:

Semaglutide 1.7 mg is a once-weekly injectable medication used as part of a weight management treatment plan. It belongs to the GLP-1 receptor agonist class and is the second-to-last step in the dose escalation schedule for patients using Semaglutide for obesity or overweight with weight-related health conditions (e.g., high blood pressure, type 2 diabetes, or high cholesterol).

This dose is commonly associated with Wegovy (a brand of Semaglutide approved for chronic weight management) and is prescribed after patients tolerate lower doses like 0.25 mg, 0.5 mg, and 1.0 mg.

How It Works:
Semaglutide mimics the GLP-1 hormone to:

• Reduce appetite and cravings

• Slow digestion and promote early satiety

• Regulate blood sugar and insulin levels

• Support consistent, sustainable weight loss

Administration:

• Subcutaneous injection once per week

• Can be injected into the abdomen, thigh, or upper arm

• Provided in a prefilled pen, easy to use at home

Who It’s For:

• Adults with a BMI ≥30 (obese), or ≥27 (overweight) with a weight-related medical condition

• Patients who have successfully completed the dose escalation process

• Individuals under the care of a licensed healthcare provider for long-term weight management

Key Benefits:

• Significant weight loss support when paired with diet and physical activity

• Helps control appetite and reduce caloric intake

• May improve metabolic health markers (blood sugar, cholesterol, blood pressure)

Semaglutide 1.7 mg is primarily used as part of a medical weight loss plan. It’s one of the final dose steps before reaching the full 2.4 mg maintenance dose used in Wegovy.

Yes, Semaglutide is FDA-approved for chronic weight management under the Wegovy brand. The 1.7 mg dose is part of the stepwise titration required to safely reach the full 2.4 mg dose.

Gradual dose escalation (starting at 0.25 mg) helps your body adjust and minimizes side effects like nausea or stomach discomfort.

Once per week, on the same day each week, with or without food.

It is typically a step toward the full 2.4 mg maintenance dose, but some patients may remain on 1.7 mg if they experience good results or cannot tolerate higher doses. Your doctor will advise what’s best for you.

Common side effects include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Headache

• Decreased appetite

• Fatigue

These often lessen over time or with dose adjustments.

It is injected under the skin using a prefilled pen. The injection is quick and can be done at home after proper training.

• Unused pens: Refrigerate at 36°F to 46°F (2°C to 8°C)

• In-use pens: May be kept at room temperature (below 86°F or 30°C) for up to 56 days

A balanced, reduced-calorie diet and increased physical activity are recommended for best results. Your provider or a nutritionist may give you personalized guidance.